{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:55:25Z","timestamp":1790744125384,"version":"4.1.0"},"reference-count":67,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T00:00:00Z","timestamp":1548892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.00100","type":"journal-article","created":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T04:15:23Z","timestamp":1548908123000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":73,"title":["The Long Non-coding RNA NRIR Drives IFN-Response in Monocytes: Implication for Systemic Sclerosis"],"prefix":"10.3389","volume":"10","author":[{"given":"Barbara","family":"Mariotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nila Hendrika","family":"Servaas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Rossato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Tamassia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco A.","family":"Cassatella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Cossu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Beretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"van der Kroef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy R. D. J.","family":"Radstake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Bazzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,1,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.smim.2003.10.003","article-title":"TLR signaling pathways","volume":"16","author":"Takeda","year":"2004","journal-title":"Semin Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type i interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"8391230","DOI":"10.1155\/2017\/8391230","article-title":"The role of toll-like receptors in autoimmune diseases through failure of the self-recognition mechanism","volume":"2017","author":"Farrugia","year":"2017","journal-title":"Int J Inflam"},{"key":"B4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2147\/ITT.S89795","article-title":"Toll-like receptors in the pathogenesis of autoimmune diseases: recent and emerging translational developments","volume":"5","author":"Duffy","year":"2016","journal-title":"ImmunoTargets Ther"},{"key":"B5","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/s11926-014-0474-z","article-title":"Emerging roles of innate immune signaling and toll-like receptors in fibrosis and systemic sclerosis","volume":"17","author":"Bhattacharyya","year":"2015","journal-title":"Curr Rheumatol Rep"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1017\/erm.2013.10","article-title":"Role of toll-like receptors in systemic sclerosis","volume":"15","author":"Ciechomska","year":"2013","journal-title":"Expert Rev Mol Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"72","DOI":"10.2174\/1874312901206010072","article-title":"New insights into the mechanisms of innate immune receptor signalling in fibrosis","volume":"6","author":"Lafyatis","year":"2012","journal-title":"Open Rheumatol J"},{"key":"B8","doi-asserted-by":"publisher","first-page":"232ra50","DOI":"10.1126\/scitranslmed.3008264","article-title":"FibronectinEDA promotes chronic cutaneous fibrosis through toll-like receptor signaling","volume":"6","author":"Bhattacharyya","year":"2014","journal-title":"Sci Transl Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1136\/annrheumdis-2013-205013","article-title":"Proteomic analysis of plasma identifies the Toll-like receptor agonists S100A8\/A9 as a novel possible marker for systemic sclerosis phenotype","volume":"73","author":"Van Bon","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ajpath.2012.09.007","article-title":"Toll-like receptor 4 signaling augments transforming growth factor-\u03b2 responses: a novel mechanism for maintaining and amplifying fibrosis in scleroderma","volume":"182","author":"Bhattacharyya","year":"2013","journal-title":"Am J Pathol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1136\/ard.2009.121400","article-title":"Type I interferon system activation and association with disease manifestations in systemic sclerosis","volume":"69","author":"Eloranta","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1002\/art.22382","article-title":"A macrophage marker, siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists","volume":"56","author":"York","year":"2007","journal-title":"Arthritis Rheum"},{"key":"B13","first-page":"694","article-title":"Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients","volume-title":"Rheumatology","author":"Tan","year":"2006"},{"key":"B14","first-page":"625","article-title":"Systemic sclerosis developing in association with the use of interferon alpha therapy for chronic viral hepatitis","volume":"22","author":"Solans","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"B15","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/1529-0131(199902)42:2<299::AID-ANR12>3.0.CO;2-R","article-title":"Interferon-? does not improve outcome at one year in patients with diffuse cutaneous scleroderma: results of a randomized, double-blind, placebo-controlled trial","volume":"42","author":"Black","year":"1999","journal-title":"Arthritis Rheum"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1136\/annrheumdis-2015-207392","article-title":"The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis","volume":"75","author":"Brkic","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00011-017-1106-7","article-title":"Increased frequencies of circulating CXCL10-, CXCL8- and CCL4-producing monocytes and Siglec-3-expressing myeloid dendritic cells in systemic sclerosis patients","volume":"67","author":"Carvalheiro","year":"2018","journal-title":"Inflamm Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1002\/art.40243","article-title":"Earliest phase of systemic sclerosis typified by increased levels of inflammatory proteins in the serum","volume":"69","author":"Cossu","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B19","doi-asserted-by":"crossref","first-page":"126","DOI":"10.20411\/pai.v3i1.252","article-title":"Long non-coding RNA-mediated regulation of the interferon response: a new perspective on a familiar theme","volume":"3","author":"Valadkhan","year":"2018","journal-title":"Pathog Immun"},{"key":"B20","first-page":"177","article-title":"Transcriptional and post-transcriptional gene regulation by long non-coding RNA","volume-title":"Genom Proteom Bioinformat.","author":"Dykes","year":"2017"},{"key":"B21","first-page":"945","article-title":"Roles for long non-coding RNAs in physiology and disease","volume-title":"Pflugers Arch","author":"Melissari","year":"2016"},{"key":"B22","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.coi.2013.12.001","article-title":"Long noncoding RNAs in innate and adaptive immunity","volume":"26","author":"Fitzgerald","year":"2014","journal-title":"Curr Opin Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.it.2014.07.005","article-title":"Long non-coding RNAs in the regulation of the immune response","volume":"35","author":"Heward","year":"2014","journal-title":"Trends Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3389\/fimmu.2014.00573","article-title":"Long non-coding rnas involved in immune responses","volume":"5","author":"Imamura","year":"2014","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.1096\/fj.14-260323","article-title":"Noncoding RNAs, cytokines, and inflammation-related diseases","volume":"29","author":"Marques-Rocha","year":"2015","journal-title":"FASEB J"},{"key":"B26","first-page":"792","article-title":"Long noncoding RNA in hematopoiesis and immunity","volume-title":"Immunity","author":"Satpathy","year":"2015"},{"key":"B27","doi-asserted-by":"publisher","first-page":"848790","DOI":"10.1155\/2015\/848790","article-title":"The emerging functions of long noncoding rna in immune cells: autoimmune diseases","volume":"2015","author":"Sigdel","year":"2015","journal-title":"J Immunol Res"},{"key":"B28","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3389\/fimmu.2014.00513","article-title":"Small and long regulatory RNAs in the immune system and immune diseases","volume":"5","author":"Stachurska","year":"2014","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/icb.2015.2","article-title":"Long noncoding RNAs: A potent source of regulation in immunity and disease","volume":"93","author":"Yu","year":"2015","journal-title":"Immunol Cell Biol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1016\/j.drudis.2011.09.009","article-title":"Classification criteria for systemic sclerosis: an ACR-EULAR collaborative initiative","volume":"11","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheumatol"},{"key":"B31","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"Carwile LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"B32","first-page":"1573","article-title":"Criteria for the classification of early systemic sclerosis","volume":"28","author":"LeRoy","year":"2001","journal-title":"J Rheumatol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.jaci.2016.06.025","article-title":"The importance of being \u201cpure\u201d neutrophils","volume":"139","author":"Calzetti","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"10668","DOI":"10.1093\/nar\/gku713","article-title":"Negative regulation of the interferon response by an interferon-induced long non-coding RNA","volume":"42","author":"Kambara","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"B35","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2018-214295","article-title":"Histone modifications underlie monocyte dysregulation in Systemic Sclerosis patients, underlining the treatment potential of epigenetic targeting","volume-title":"Ann Rheum Dis.","author":"van der Kroef","year":""},{"key":"B36","first-page":"1105","article-title":"TopHat: discovering splice junctions with RNA-Seq","volume-title":"Bioinformatics","author":"Trapnell","year":"2009"},{"key":"B37","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"B38","first-page":"166","article-title":"HTSeq-A Python framework to work with high-throughput sequencing data","volume-title":"Bioinformatics","author":"Anders","year":"2015"},{"key":"B39","doi-asserted-by":"publisher","first-page":"W305","DOI":"10.1093\/nar\/gkp427","article-title":"ToppGene suite for gene list enrichment analysis and candidate gene prioritization","volume":"37","author":"Chen","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"B40","first-page":"559","article-title":"WGCNA: an R package for weighted correlation network analysis","volume-title":"BMC Bioinformatics","author":"Langfelder","year":"2008"},{"key":"B41","first-page":"e21800","article-title":"Revigo summarizes and visualizes long lists of gene ontology terms","volume-title":"PLoS ONE","author":"Supek","year":"2011"},{"key":"B42","first-page":"302","article-title":"A new measure for functional similarity of gene products based on gene ontology","volume-title":"BMC Bioinformatics","author":"Schlicker","year":"2006"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"B44","first-page":"1372","article-title":"Processing of gene expression data generated by quantitative real-time RT-PCR","volume-title":"Biotechniques","author":"Muller","year":"2002"},{"key":"B45","first-page":"119","article-title":"Cytokine multiplex immunoassay: methodology and (clinical) applications","volume-title":"Methods Mol Biol.","author":"de Jager","year":"2009"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1038\/nsmb.2428","article-title":"Cis-acting noncoding RNAs: friends and foes","volume":"19","author":"Guil","year":"2012","journal-title":"Nat Struct Mol Biol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/ni774","article-title":"TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha\/beta-dependent gene expression in macrophages","volume":"3","author":"Toshchakov","year":"2002","journal-title":"Nat Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"7344","DOI":"10.4049\/JIMMUNOL.178.11.7344","article-title":"The MyD88-independent pathway is not mobilized in human neutrophils stimulated via TLR4","volume":"178","author":"Tamassia","year":"2007","journal-title":"J Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/art.37742","article-title":"Correlation of interferon-inducible chemokine plasma levels with disease severity in systemic sclerosis","volume":"65","author":"Liu","year":"2013","journal-title":"Arthritis Rheum"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1136\/annrheumdis-2018-213257","article-title":"Association of circulating CXCL10 and CXCL11 with systemic sclerosis","volume":"77","author":"Crescioli","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"B51","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12931-016-0493-6","article-title":"Gene profile of fibroblasts identify relation of CCL8 with idiopathic pulmonary fibrosis","volume":"18","author":"Lee","year":"2017","journal-title":"Respir Res"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1017\/erm.2013.10","article-title":"Role of toll-like receptors in systemic sclerosis","volume":"15","author":"Ciechomska","year":"2013","journal-title":"Expert Rev Mol Med"},{"key":"B53","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1042\/CS20130367","article-title":"Innate immunity in systemic sclerosis pathogenesis","volume":"126","author":"O'Reilly","year":"2014","journal-title":"Clin Sci"},{"key":"B54","first-page":"e33508","article-title":"Differentiation potential of CD14+ monocytes into myofibroblasts in patients with systemic sclerosis","volume-title":"PLoS ONE","author":"Binai","year":"2012"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1007\/s10067-017-3597-6","article-title":"CD16-positive circulating monocytes and fibrotic manifestations of systemic sclerosis","volume":"36","author":"Lescoat","year":"2017","journal-title":"Clin Rheumatol"},{"key":"B56","first-page":"e98850","article-title":"TLR4-dependent fibroblast activation drives persistent organ fibrosis in skin and lung","volume-title":"JCI Insight","author":"Bhattacharyya","year":"2018"},{"key":"B57","first-page":"707","article-title":"Role of class II human leucocyte antigens in the progression from early to definite systemic sclerosis","volume-title":"Rheumatol","author":"Vigone","year":"2014"},{"key":"B58","doi-asserted-by":"publisher","first-page":"3902","DOI":"10.1002\/art.24038","article-title":"Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosi","volume":"58","author":"Koenig","year":"2008","journal-title":"Arthritis Rheum"},{"key":"B59","first-page":"223","article-title":"Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals","volume-title":"Nature","author":"Guttman","year":"2009"},{"key":"B60","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3389\/fimmu.2016.00535","article-title":"Interferon-induced transmembrane protein 3 inhibits hantaan virus infection, and its single nucleotide polymorphism rs12252 influences the severity of hemorrhagic fever with renal syndrome","volume":"7","author":"Xu-Yang","year":"2017","journal-title":"Front Immunol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.3389\/fimmu.2017.01038","article-title":"Catalog of differentially expressed long non-coding RNA following activation of human and mouse innate immune response","volume":"8","author":"Roux","year":"2017","journal-title":"Front Immunol"},{"key":"B62","first-page":"845","article-title":"Long intergenic noncoding rnas mediate the human chondrocyte inflammatory response and are differentially expressed in osteoarthritis cartilage","volume-title":"Arthritis Rheumatol","author":"Pearson","year":"2016"},{"key":"B63","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/art.27220","article-title":"A four-gene biomarker predicts skin disease in patients with diffuse cutaneous systemic sclerosis","volume":"62","author":"Farina","year":"2010","journal-title":"Arthritis Rheum"},{"key":"B64","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.3899\/jrheum.080418","article-title":"Upregulation of myxovirus-resistance Protein A: a possible marker of Type I interferon induction in systemic sclerosis","volume":"35","author":"Air\u00f2","year":"2008","journal-title":"J Rheumatol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1002\/art.30318","article-title":"Interferon and alternative activation of monocyte\/macrophages in systemic sclerosis-associated pulmonary arterial hypertension","volume":"63","author":"Christmann","year":"2011","journal-title":"Arthritis Rheum"},{"key":"B66","first-page":"45","article-title":"CXCL10 (\u03b1) and CCL2 (\u03b2) chemokines in systemic sclerosis - a longitudinal study","volume-title":"Rheumatology","author":"Antonelli","year":"2008"},{"key":"B67","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1038\/jid.2015.188","article-title":"Suppression of T cell activation and collagen accumulation by an anti-type I interferon receptor monoclonal antibody in adult patients with systemic sclerosis","volume":"135","author":"Guo","year":"2015","journal-title":"J Invest Dermatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00100\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T19:03:52Z","timestamp":1573844632000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00100\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,31]]},"references-count":67,"alternative-id":["10.3389\/fimmu.2019.00100"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.00100","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,31]]},"article-number":"100"}}